MedCap AB (publ) (STO:MCAP)

Market Cap	7.25B +36.0%
Revenue (ttm)	2.11B +16.6%
Net Income	219.80M +6.0%
EPS	14.67 +4.8%
Shares Out	15.02M
PE Ratio	32.92
Forward PE	26.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,707
Average Volume	12,915
Open	482.40
Previous Close	482.80
Day's Range	482.40 - 513.00
52-Week Range	353.00 - 677.00
Beta	0.51
RSI	59.93
Earnings Date	Apr 29, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orth...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 627
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MCAP

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.64% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.